Several approved medications , such as copyright and Semaglutide, belong to the incretin mimetic class . Primarily , these therapies work by mimicking naturally occurring hormones that impact glucose levels and encourage slimming. Although copyright is a specific formulation for type 2 diabetes ,

Patients struggling with obesity are often faced with limited and sometimes ineffective treatment options. However, a groundbreaking new medication, Wegovy, is rapidly changing the landscape of weight loss. Prescribed by regulatory bodies for chronic weight management, Semaglutide works as a glu